Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:14 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | CITADEL ADVISORS LLC | 368,067 0.500% | -5,038,022 (-93.19%) | View |
| 2024-10-09 4:18 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,005,598 4.200% | -764,328 (-20.27%) | View |
| 2024-07-08 4:32 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | BlackRock Inc. BLK | 2,032,464 2.900% | -3,873,408 (-65.59%) | View |
| 2024-02-14 8:32 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | Venrock Healthcare Capital Partners II L.P. | 0 0.000% | -4,563,962 (Position Closed) | View |
| 2024-02-14 5:01 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,398,453 (Position Closed) | View |
| 2024-02-14 4:58 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | CITADEL ADVISORS LLC | 5,406,089 7.600% | 1,819,325 (+50.72%) | View |
| 2024-02-14 4:13 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,769,926 5.300% | 290,565 (+8.35%) | View |
| 2024-02-14 4:00 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | TANG CAPITAL PARTNERS LP | 1,753,335 2.500% | -2,584,820 (-59.58%) | View |
| 2024-02-14 2:06 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | Rock Springs Capital Management LP | 2,998,495 4.230% | -962,754 (-24.30%) | View |
| 2024-02-14 10:30 am Sale | 13G | Aclaris Therapeutics Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,360,941 (Position Closed) | View |
| 2024-02-13 4:55 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | VANGUARD GROUP INC | 4,721,887 6.670% | 4,721,887 (New Position) | View |
| 2024-02-13 2:24 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | Foresite Capital Fund IV L.P. | 0 0.000% | -4,066,277 (Position Closed) | View |
| 2024-02-08 11:14 am Purchase | 13G | Aclaris Therapeutics Inc. ACRS | BML Investment Partners L.P. | 9,395,934 13.300% | 4,895,934 (+108.80%) | View |
| 2024-02-01 4:15 pm Sale | 13G | Aclaris Therapeutics Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,479,361 4.900% | -108,753 (-3.03%) | View |
| 2024-01-25 4:59 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | BlackRock Inc. BLK | 5,905,872 8.300% | 818,437 (+16.09%) | View |
| 2024-01-16 5:24 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | BML Investment Partners L.P. | 4,500,000 6.400% | 4,500,000 (New Position) | View |
| 2023-12-11 4:25 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,588,114 5.100% | 3,588,114 (New Position) | View |
| 2023-12-11 09:36 am Sale | 13G | Aclaris Therapeutics Inc. ACRS | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -7,372,601 (Position Closed) | View |
| 2023-11-24 1:49 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | TANG CAPITAL PARTNERS LP | 4,338,155 6.100% | 4,338,155 (New Position) | View |
| 2023-09-05 4:14 pm Purchase | 13G | Aclaris Therapeutics Inc. ACRS | CITADEL ADVISORS LLC | 3,586,764 5.100% | 3,586,764 (New Position) | View |